Clarient Q2 Revenues Up 71%
Not wanting to break a winning streak, Clarient delivered its 16th consecutive quarter of quarterly revenue growth. The company posted revenues of $16.9 million in […]
Articles by Doug Cress
NeuroMetrix: Revenues Decline, NC-Stat Prospects Bleak
NeuroMetrix reported quarterly revenues of $8.5 million yesterday, down approximately 26% from the same period in 2007. The company generated a scant $510,000 (or 6% […]
Chembio Q2 Results: Record Revenues, Net Loss Decreases
Chembio Diagnostics reported second quarter revenues of $2.72 million, an 8.6% increase over Q2 2007 and higher than any previous quarter. The lion’s share of […]
[Video] On Greatbatch, Stereotaxis: Interview with Keay Nakae, Analyst at Collins Stewart
In this video, Keay discusses Greatbatch, which he believes is a compelling buy based on its current valuation. Keay also discusses Stereotaxis. The company has […]
[Video] Medical Device Market Overview: Interview with Keay Nakae, Analyst at Collins Stewart
Some insightful commentary care of Keay Nakae, the medical device analyst at Collins Stewart. We spoke to Keay earlier this month at the firm’s annual […]
Electro-Optical Sciences Nears Pivotal Trial Completion
Electro-Optical Sciences (EOS), developer of The MelaFind System, a hand held imaging device that detects melanomas at an early stage, has completed patient accrual in […]
Langer Cuts the Fat: Sells Bi-Op Subsidiary for Less than 2003 Purchase Price
Langer, Inc. has completed the sale of Bi-Op Laboratories for $2,125,000 in cash. Buyers include a group of investors and Raynald Henry, the current Bi-Op […]
[Video] Thermage Buys Reliant for $95 Million
Some older news, in video form, care of our team at OneMedPlace TV. Thermage announced it would acquire Reliant Technologies earlier this month. The stock […]
[Video Profile] Interview with Dr. Anand Lalaji, President & CEO of The Radiology Group
The Radiology Group has developed a virtual, full-service radiology department with a complete range of specialty interpretations. The company aims to match the appropriate physician […]
NeuroMetrix Cost Cutting and Product Introductions Not Enough to Appease Investors
NeuroMetrix continues to get hammered by investors who have left the company for dead. In May, NeuroMetrix laid off 15% of its work force. The […]